An interventional study of Home-based self-exercise feedback program using video in Home Exercise Program, PD - Parkinson's Disease and Feasibility Studies, sponsored by Seoul National University Hospital. Not yet recruiting at 1 site in South Korea. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-04-15.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Parkinson Disease by Seoul National University Hospital — 2 open to participants now, 2 under way, none of them phase 3. Parkinson Disease · Seoul National University Hospital.
Among the 23 studies in Parkinson Disease by Seoul National University Hospital, this one is the 19th largest by planned enrollment of the 21 interventional ones that give a count, is the only one that started in 2026, is one of 12 with no phase, and was the 23rd registered.
4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.
Browse Parkinson Disease studies →2 of the 23 studies in Parkinson Disease by Seoul National University Hospital are open now, in 1 country. Recruiting first, the newest first:
Seoul National University Hospital · Sites in Korea, Republic of
By country, each count listing its studies:
Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.
This study: 19 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 15 is below the median of 40 across 3,360 interventional studies indexed under Parkinson Disease.
Median enrollment 40 across the 21 interventional studies, 650 across the 2 observational. Of the 12 that completed or were terminated, 1 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
Seoul National University Hospital is the lead sponsor of 1,903 studies on the registry; 276 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
1 of the studies in Parkinson Disease by Seoul National University Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07522138Seoul National University HospitalHome-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study | 2026-12-01 |
Add it to your calendar (.ics) → With an account.
Among the 23 studies in Parkinson Disease by Seoul National University Hospital, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to test whether patients with Parkinson's disease can safely and effectively use a home-based exercise program guided by videos. Participants will follow video instructions for exercises at home while their movements are monitored by a camera, which provides real-time feedback. The study will check how well participants complete the exercises, their satisfaction with the program, and any changes in clinical function. The goal is to see if this type of home exercise can help patients increase their activity levels without significant side effects.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants follow a 6-week home-based exercise program guided by instructional videos, including stretching, strength, balance, aerobic, and LSVT-specific exercises. A camera provides real-time feedback using the iPixel exercise feedback system, and participants complete sessions at least 5 times per week, 40 minutes per session, with weekly 30-minute in-person check-ins for monitoring and support.
Behavioral: Home-based self-exercise feedback program using video
Participants follow a 6-week home-based exercise program using video-guided instructions and the iPixel exercise feedback system, which monitors movements in real-time and provides corrective feedback. The program includes: Stretching exercises, Strength training, Balance exercises, Aerobic exercises, LSVT-specific exercises. Participants are instructed to complete sessions at least 5 times per week, 40 minutes per session. Additionally, weekly 30-minute in-person rehabilitation sessions are conducted to adjust the next week's exercise intensity based on each participant's functional level.
Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Part III (Motor Examination)
0 to 108, with higher scores indicating worse motor function.
Time frame: From enrollment to the end of treatment at 6 weeks
Modified Hoehn and Yahr sacle
Modified Hoehn and Yahr Scale Score range: 0 to 5, with higher scores indicating more severe disease stage.
Time frame: From enrollment to the end of treatment at 6 weeks
Berg Balance Scale
0 to 56, with higher scores indicating better balance ability.
Time frame: From enrollment to the end of treatment at 6 weeks
Functional Gait Ability
0 to 30, with higher scores indicating better gait function.
Time frame: From enrollment to the end of treatment at 6 weeks
Freezing of Gait Questionnaire
0 to 24, with higher scores indicating more severe freezing of gait.
Time frame: From enrollment to the end of treatment at 6 weeks
EuroQol-5 Dimention Questionnaire
0 to 1, with higher scores indicating better health-related quality of life.
Time frame: From enrollment to the end of treatment at 6 weeks
Plan to share: Undecided
Start is estimated for Apr 2026; primary completion for Dec 2026, 7 months later.
Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 7 months is below that.
Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital →